These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2310031)

  • 1. Comparison of anticholinesterases and their effects on acetylcholine-activated ion channels.
    Wachtel RE
    Anesthesiology; 1990 Mar; 72(3):496-503. PubMed ID: 2310031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of edrophonium, physostigmine and methanesulfonyl fluoride with the snake end-plate acetylcholine receptor-channel complex.
    Fiekers JF
    J Pharmacol Exp Ther; 1985 Sep; 234(3):539-49. PubMed ID: 2411911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium.
    Bartkowski RR
    Anesth Analg; 1987 Jul; 66(7):594-8. PubMed ID: 3605668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor.
    Yost CS; Maestrone E
    Anesth Analg; 1994 Mar; 78(3):520-6. PubMed ID: 8109771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium.
    Valdrighi JB; Fleming NW; Smith BK; Baker GL; White DA
    Br J Anaesth; 1994 Feb; 72(2):237-9. PubMed ID: 8110583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contractile and phosphatidylinositol responses of rat trachea to anticholinesterase drugs.
    Shibata O; Tsuda A; Makita T; Iwanaga S; Hara T; Shibata S; Sumikawa K
    Can J Anaesth; 1998 Dec; 45(12):1190-5. PubMed ID: 10051938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
    Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
    Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.
    Ferguson A; Egerszegi P; Bevan DR
    Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the anticholinesterase and anticurare effects of some cholinesterase inhibitors.
    Barrow ME; Johnson JK
    Br J Anaesth; 1966 Jun; 38(6):420-31. PubMed ID: 5944020
    [No Abstract]   [Full Text] [Related]  

  • 10. A test for the assessment of the duration of the action of neostigmine and of the relative potencies of various anticholinesterases using the pupil of the mouse.
    Schneider R
    J Pharm Pharmacol; 1970 Apr; 22(4):298-301. PubMed ID: 4392572
    [No Abstract]   [Full Text] [Related]  

  • 11. A dose-response study of anticholinesterase drugs on contractile and phosphatidylinositol responses of rat trachea.
    Tsuda A; Shibata O; Saito M; Hashimoto S; Iwanaga S; Makita T; Sumikawa K
    Anesth Analg; 2001 Jan; 92(1):100-5. PubMed ID: 11133609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct actions of anticholinesterases on the neuronal nicotinic acetylcholine receptor channels.
    Nagata K; Huang CS; Song JH; Narahashi T
    Brain Res; 1997 Sep; 769(2):211-8. PubMed ID: 9374188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium.
    Barber HE; Calvey TN; Muir KT
    Br J Pharmacol; 1979 Aug; 66(4):525-30. PubMed ID: 223706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
    Fleming NW; Lewis BK
    Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological estimation of the actions of acetylcholinesterase inhibitors on acetylcholine receptor and cholinesterase in physically isolated Aplysia neurones.
    Oyama Y; Hori N; Evans ML; Allen CN; Carpenter DO
    Br J Pharmacol; 1989 Mar; 96(3):573-82. PubMed ID: 2720293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of neuromuscular blockade.
    Bevan DR; Donati F; Kopman AF
    Anesthesiology; 1992 Oct; 77(4):785-805. PubMed ID: 1416176
    [No Abstract]   [Full Text] [Related]  

  • 18. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of nifedipine and diltiazem with muscle relaxants and reversal of neuromuscular blockade with edrophonium and neostigmine.
    Wali FA
    J Pharmacol; 1986; 17(3):244-53. PubMed ID: 3795969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.
    Yamamoto K; Sawada Y; Iga T
    J Pharmacokinet Biopharm; 1996 Aug; 24(4):327-48. PubMed ID: 9044164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.